Figure 2: a) neoplastic complications occurred in transplant patients undergoing tacrolimus therapy during seven years of follow-up; AK and NMSC were significantly more prevalent than MM (*p<0.05); b) different NMSC occurred in transplanted patients undergoing tacrolimus therapy during seven years followup. BCC was more prevalent than Kaposi's sarcoma (*p<0.05) (KAP) Kaposi’s sarcoma.